News & Events
We keep you up to date with our latest news.
- SYMYOO to Showcase Clinical Research Excellence at Bio Korea 2025 07 May 2025 - Symyoo, a leading full-service CRO with over 15 years of experience in clinical development, is participating in Bio Korea 2025. The company brings extensive expertise conducting over 250 clinical studies across more than 30 therapeutic areas, including oncology, rare diseases, neurology, and infectious diseases. Notably, two-thirds of Symyoo’s clinical trials have been registrational studies, highlighting ... SYMYOO to Showcase Clinical Research Excellence at Bio Korea 2025
- SYMYOO Officially Launches Phase 1 of Its Next-Generation Clinical Trial Management System (CTMS) 02 May 2025 - SYMYOO, a full service CRO and digital healthcare technology company, has officially announced the launch of Phase 1 of its SYNeRA™️ Clinical Trial Management System (CTMS). This release marks a significant step toward streamlining clinical trial operations and ensuring high-quality data through an integrated digital solution, setting a new standard for clinical trial digitization. All-in-one, ... SYMYOO Officially Launches Phase 1 of Its Next-Generation Clinical Trial Management System (CTMS)
- SYMYOO Selected as CRO for the Large-Scale RRCT “iTARGET-Elderly Study” 02 Jan 2025 - SYMYOO was selected as CRO for iTARGET-Elderly Study, a large-scale registry-based randomized controlled trial (RRCT) led by the Korean Diabetes Association (KDA). This study will compare and evaluate moderate-intensity statin therapy with an individualized LDL-C target-based therapy for the primary prevention effects of cardiovascular events in elderly patients with type 2 diabetes. The large-scale study ... SYMYOO Selected as CRO for the Large-Scale RRCT “iTARGET-Elderly Study”
- SYMYOO, Leading the Way in Digitalized Clinical Research 07 Oct 2024 - SYMYOO is on track to become the most digitalized CRO by integrating advanced IT solutions into its home-grown EDC/ Clinical Trial Management System, in order to streamline patient recruitment and to boost trial efficiency. By combining proprietary digital systems with expert personnel, Symyoo has successfully launched the Man-Unmanned Teaming Clinical Trial (MUM-T CT) model, driving innovation ... SYMYOO, Leading the Way in Digitalized Clinical Research
- SYMYOO Supports Korea Diabetes Association (KDA)’s large-scale RRCT, REMATCH 04 Jan 2024 - As a National Coordination Center, SYMYOO conducts REMATCH study, which is a very large-scale Registry-based Randomized Clinical Trial (RRCT) sponsored by the Korea Diabetes Association (KDA). This REMATCH study aims to define optimal type 2 diabetes management strategies that will improve cardiovascular and renal outcomes in type 2 diabetes mellitus patient population. Over 60 clinical ... SYMYOO Supports Korea Diabetes Association (KDA)’s large-scale RRCT, REMATCH
- Launch of SYNeRAᵀᴹ Platform DB Engine 24 Mar 2023 - Smart Trial Research Center (STRC) at SYMYOO launches a new database engine, developed with multi-tier system architecture, meta-data driven and hierarchically structured database design. This SYNeRAᵀᴹ DB engine is optimized considering the systemic structural characteristics that easily reflect various system requirements from simple clinical studies to large-scale, multinational, and multi-center late-stage clinical trials, while enabling ... Launch of SYNeRAᵀᴹ Platform DB Engine
- Dodlab, an IT Platform Company Launched 01 Nov 2022 - Symyoo established Dodlab, Inc., to create new innovations and values under the vision ‘Making the Better Place to Live with IT Technologies’. Dodlab will pioneer new areas in the many industrial sectors, including the healthcare arena, and develop into a leading IT technology company with excellence in technology and expertise in order to help their ... Dodlab, an IT Platform Company Launched
- Global Coordinating Center For Late Phase Covid-19 Trials 14 Mar 2022 - Symyoo was designated as a global coordinating center to run late phase multinational clinical trials for Covid-19 medication development. The trials are conducted widely across Korea and European countries. Symyoo understands well that the trial operations should be very specific to the risk and complexity of each region/country where the trials are conducted.
- SYMYOO America, Inc. Established 01 Nov 2021 - Established Symyoo America, Inc. in order to provide global trial consulting services for the Korean pharmaceutical, biotechnology and life-science companies wishing to enter the global market.
- Korea CDISC Coordinating Committee (K3C), CDISC/SDTM Industry Partner 03 Nov 2019 - Symyoo participated in Korea CDISC Coordinating Committee (K3C) and achieved CDISC/SCDM industry partnership, which is granted to a company having comprehensive data management capability for clinical research.
- IWRS, RBM Integration Into SYMYOO EDC, SYNeRA™ 05 Mar 2019 - Symyoo EDC system, SYNeRA™, expanded its functionalities by integrating new modules, including IWRS (Interactive Web-based Randomization System), IP Accountability (Investigational Product Tracking and Management System), and RBM (Risk-Based Monitoring System). Symyoo IWRS can handle various randomization algorithms from simple permuted block randomization to very complex covariate adaptive randomization (biased coin, minimum sufficient).
- 150+ Trials And 30th Oncology Trial On SYMYOO’s 9th Anniversary 23 Nov 2018 - Conducted more than 150 clinical studies, including 30 oncology trials over 9 years since its foundation in 2009. Symyoo had been coordinating and collaborating with various
- Introducing SYMYOO EDC, SYNeRA™ 24 Feb 2016 - Launched Symyoo EDC system, SYNeRA™ for clinical research data collection and management. Symyoo SMART TRIALS research center continues to develop and expand SYNeRA™ functionalities into a web-based Comprehensive Clinical Trial Management System.
- Partnership With KU Anam Hospital 12 Oct 2015 - Began research collaboration with Global Clinical Trial Center of Anam Hospital, Korea University Medical Center
- Korea CRO Association Member 15 Sep 2014 - Qualified for full membership in Korea Clinical Trial CRO Association.
- SMART TRIALS Research Center 21 Jul 2014 - Established SMART TRIALS center to research and facilitate new IT technologies for tomorrow’s medicines. Symyoo reorganized data management and biostatistics team to offer broader data management services.
- Partnership With Inje Clinical Trial Center 01 Sep 2013 - Partnership contract with Clinical Trial Center of Baek University Hospital, Inje University
- First Global Phase III Trial As Coordinating Center 12 Nov 2012 - Symyoo was designated as the Korea coordinating center to run a multinational phase III clinical trial, which was the first NIH/NINDS study (ATACH 2: Antihypertensive Treatment of Acute Cerebral Hemorrhage II) operated in South Korea. The sponsor audit was also conducted to evaluate trial conduct and compliance with the protocol and SOPs without finding any ... First Global Phase III Trial As Coordinating Center
- First Phase III Pivotal Trial 07 Mar 2010 - Symyoo expanded its business into a full scope CRO and began to operate a first phase III trial for premature ejaculation study.
- SYMYOO Founded 23 Nov 2009 - Dongjin Yoo, CEO & MD, founded a CRO to help K-Bio industry’s clinical development after his successful journey as a CEO and medical director of many global pharmaceuticals and bio startups.
